Browsing Tag
Overactive bladder
5 posts
New drug launch sends Lupin shares soaring to record highs! Find out what’s next
Lupin Limited, a global pharmaceutical major, has seen its share price reach a 52-week high following the launch…
September 5, 2024
Lupin secures US FDA approval for generic Fesoterodine Fumarate Extended-Release Tablets in overactive bladder treatment market
Lupin secures US FDA approval for generic Fesoterodine Fumarate ER tablets, entering a USD 177M overactive bladder market in the United States.
January 8, 2023
Zydus Lifesciences gets final FDA approval for Mirabegron generic
Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has secured final approval from…
October 4, 2022
Alembic Pharmaceuticals gets FDA approval for Toviaz generic
Alembic Pharmaceuticals said that it has secured tentative approval from the US Food & Drug Administration (FDA) for…
February 2, 2022
Urovant Sciences acquires licensing for hMaxi-K gene therapy to treat overactive bladder from Ion Channel
Urovant Sciences has secured global licensing rights from Ion Channel Innovations for the development and commercialization of a…
August 29, 2018